While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Arialief is a comprehensive nerve health supplement that specifically targets sciatic nerve pain and claims to provide ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.